362 related articles for article (PubMed ID: 34943855)
1. Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia.
Xu H; Yu H; Jin R; Wu X; Chen H
Cells; 2021 Nov; 10(12):. PubMed ID: 34943855
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Modifications in Acute Lymphoblastic Leukemia: From Cellular Mechanisms to Therapeutics.
Fathi E; Farahzadi R; Montazersaheb S; Bagheri Y
Curr Gene Ther; 2021; 21(1):60-71. PubMed ID: 33183201
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics in pediatric acute lymphoblastic leukemia.
Nordlund J; Syvänen AC
Semin Cancer Biol; 2018 Aug; 51():129-138. PubMed ID: 28887175
[TBL] [Abstract][Full Text] [Related]
4. [Epigenetic alterations in acute lymphoblastic leukemia].
Navarrete-Meneses MDP; Pérez-Vera P
Bol Med Hosp Infant Mex; 2017; 74(4):243-264. PubMed ID: 29382514
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemia.
San Jose-Eneriz E; Agirre X; Rodríguez-Otero P; Prosper F
Epigenomics; 2013; 5(5):525-38. PubMed ID: 24059799
[TBL] [Abstract][Full Text] [Related]
6. Targeting epigenetics through histone deacetylase inhibitors in acute lymphoblastic leukemia.
Mummery A; Narendran A; Lee KY
Curr Cancer Drug Targets; 2011 Sep; 11(7):882-93. PubMed ID: 21762078
[TBL] [Abstract][Full Text] [Related]
7. The landscape of alterations affecting epigenetic regulators in T-cell acute lymphoblastic leukemia: Roles in leukemogenesis and therapeutic opportunities.
Walia Y; de Bock CE; Huang Y
Int J Cancer; 2024 May; 154(9):1522-1536. PubMed ID: 38155420
[TBL] [Abstract][Full Text] [Related]
8. Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia.
Rahmani M; Talebi M; Hagh MF; Feizi AAH; Solali S
Biomed Pharmacother; 2018 Jan; 97():1493-1500. PubMed ID: 29793312
[TBL] [Abstract][Full Text] [Related]
9. Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia.
Figueroa ME; Chen SC; Andersson AK; Phillips LA; Li Y; Sotzen J; Kundu M; Downing JR; Melnick A; Mullighan CG
J Clin Invest; 2013 Jul; 123(7):3099-111. PubMed ID: 23921123
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.
Kuang SQ; Fang Z; Zweidler-McKay PA; Yang H; Wei Y; Gonzalez-Cervantes EA; Boumber Y; Garcia-Manero G
PLoS One; 2013; 8(4):e61807. PubMed ID: 23637910
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Overview of Recent Advances in Epigenetics in Pediatric Acute Lymphoblastic Leukemia.
Drożak P; Bryliński Ł; Zawitkowska J
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358802
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics of acute lymphocytic leukemia.
Garcia-Manero G; Yang H; Kuang SQ; O'Brien S; Thomas D; Kantarjian H
Semin Hematol; 2009 Jan; 46(1):24-32. PubMed ID: 19100365
[TBL] [Abstract][Full Text] [Related]
13. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
[TBL] [Abstract][Full Text] [Related]
14. Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia.
Mar BG; Bullinger LB; McLean KM; Grauman PV; Harris MH; Stevenson K; Neuberg DS; Sinha AU; Sallan SE; Silverman LB; Kung AL; Lo Nigro L; Ebert BL; Armstrong SA
Nat Commun; 2014 Mar; 5():3469. PubMed ID: 24662245
[TBL] [Abstract][Full Text] [Related]
15. 3D environment controls H3K4 methylation and the mechanical response of the nucleus in acute lymphoblastic leukemia cells.
González-Novo R; de Lope-Planelles A; Cruz Rodríguez MP; González-Murillo Á; Madrazo E; Acitores D; García de Lacoba M; Ramírez M; Redondo-Muñoz J
Eur J Cell Biol; 2023 Sep; 102(3):151343. PubMed ID: 37494871
[TBL] [Abstract][Full Text] [Related]
16. The importance of miRNAs and epigenetics in acute lymphoblastic leukemia prognosis.
Ranjbar R; Karimian A; Aghaie Fard A; Tourani M; Majidinia M; Jadidi-Niaragh F; Yousefi B
J Cell Physiol; 2019 Apr; 234(4):3216-3230. PubMed ID: 29384211
[TBL] [Abstract][Full Text] [Related]
17. CREBBP mutations in relapsed acute lymphoblastic leukaemia.
Mullighan CG; Zhang J; Kasper LH; Lerach S; Payne-Turner D; Phillips LA; Heatley SL; Holmfeldt L; Collins-Underwood JR; Ma J; Buetow KH; Pui CH; Baker SD; Brindle PK; Downing JR
Nature; 2011 Mar; 471(7337):235-9. PubMed ID: 21390130
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modifications in pediatric acute lymphoblastic leukemia.
Burke MJ; Bhatla T
Front Pediatr; 2014; 2():42. PubMed ID: 24860797
[TBL] [Abstract][Full Text] [Related]
19. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
Chung C; Ma H
Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
[TBL] [Abstract][Full Text] [Related]
20. Preserved global histone H4 acetylation linked to ETV6-RUNX1 fusion and PAX5 deletions is associated with favorable outcome in pediatric B-cell progenitor acute lymphoblastic leukemia.
Janczar K; Janczar S; Pastorczak A; Mycko K; Paige AJ; Zalewska-Szewczyk B; Wagrowska-Danilewicz M; Danilewicz M; Mlynarski W
Leuk Res; 2015 Dec; 39(12):1455-61. PubMed ID: 26520622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]